Close Menu

NEW YORK – Syapse said Tuesday that it has raised $68 million in new equity financing. Ally Bridge Group led the round, with participation from new investor Northpond Ventures and several unspecified existing investors.

As a result of the investment, Northpond Ventures Director Andrea Jackson has been named to the Syapse board of directors. 

In a statement, Jackson said that Syapse's strategy of applying real-world data and evidence to cancer care is "foundational for drug developers, regulators, doctors, and caregivers."

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.